Michael Palfreyman is a seasoned leader in the biotechnology and pharmaceutical industries with over 40 years of experience and a pioneer in psychedelic therapy. Now head of R&D for Cybin, he sits down with Anthony Lacavera to discuss where psychedelic therapies like psilocybin are today and how the work he's doing will bring them into the mainstream.
